Skip to main content
Pablo Martínez-Puig on Muck Rack

Pablo Martínez-Puig

As seen in: PLOS ONE
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Pablo

Contact Pablo, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Systematic evaluation of subgroup analyses of inhaled treprostinil in pulmonary hypertension due to interstitial lung disease

|
By Nerea Báez-Gutiérrez, Héctor Rodríguez-Ramallo, Pablo Martínez-Puig, Laila Abdelkader-Martin
| PLOS ONE
Discussion There are several challenges associated with conducting clinical trials for treatments targeting PH associated with lung diseases or hypoxia. Historically, these trials have yielded a mixture of negative and detrimental results [13, 18–26]. Therefore, investigators of the INCREASE trial deserve commendation for their contributions to the field of PH. Their work has provided valuable insight into this disorder and reported the efficacy of a drug for treating group 3 PH patients.
Open in Who Shared Issue with article?
See all 1 articles